Clinical Trials Browser

Phase 1/2 × Lymphoma, Non-Hodgkin × umbralisib × Clear all

NCT03379051 2022-08-22

Phase I/II Study of Venetoclax or Lenalidomide in Combination With Ublituximab and Umbralisib in Subjects With Relapsed or Refractory CLL/SLL and NHL

Phase 1/2 Terminated

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT02867618 2021-07-16

Carfilzomib and TGR-1202 in Treatment of R/R Lymphoma

Phase 1/2 Terminated

14 enrolled 9 charts

Hodgkin Disease, Lymphoma, Non-Hodgkin